June 20, 2020Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer Read more »
May 25, 2021Visceral obesity promotes lung cancer progression – towards resolution of the obesity paradox in lung cancer Read more »
November 1, 2021Molecular profiling of metastatic renal cell carcinoma treated with ipilimumab-nivolumab Read more »
April 16, 2021Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions Read more »
December 2, 2021A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors Read more »
July 7, 2021Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response Read more »
July 22, 2021Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience Read more »
September 1, 2021Diverse RNA expression patterns of T cell priming markers in various solid tumors and their clinical implication Read more »
